AI Analysis AI Analysis of ALPMF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add ALPMF to Watchlist?
Some Reasons Why To Add ALPMF:
  • Excellent financial health (Piotroski 8/9)
  • Healthy interest coverage ratio of 28.8x
  • Lower volatility than the market (beta 0.08)
PDF

High volatility in Astellas Pharma, Inc. stock price on Friday which ended trading at $12.85
(Updated on Jul 10, 2026)

Hold candidate since Jul 10, 2026

No changes to the price of Astellas Pharma, Inc. stock on the last trading day (Friday, 10th Jul 2026). During the last trading day the stock fluctuated 13.62% from a day low at $12.85 to a day high of $14.60. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.57% during the next 3 months and, with a 90% probability hold a price between $9.36 and $11.86 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ALPMF Signals & Forecast

There are mixed signals in the stock today. The Astellas Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.72 and $13.88. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Astellas Pharma, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.75 between high and low, or 13.62%. For the last week, the stock has had daily average volatility of 6.85%.

Our recommended stop-loss: $12.06 (-6.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 11 days ago.)

Trading Expectations (ALPMF) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Astellas Pharma, Inc. to open at $13.43, and during the day (based on 14 day Average True Range), to move between $12.40 and $13.30, which gives a possible trading interval of +/-$0.91 (+/-7.34%) up or down from last closing price. If Astellas Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.34% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $13.75, some $0.90 (7.00%) from the current price of $12.85, our system finds the risk reward not very attractive.

Dividend Warning For ALPMF

Dividend coming up for ALPMF: Ex-dividend date (Tuesday 29th September, 2026) is 79 days away. The dividend is $0.200.

Is Astellas Pharma, Inc. stock A Buy?

Astellas Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $13.43 ( 4.54%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

ALPMF Performance

Trading levels for ALPMF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 15.18 18.16%
R2 14.51 12.96%
R1 14.10 9.74%
Price 12.85
S1 12.76 -0.663%
S2 12.35 -3.88%
S3 11.68 -9.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 14.96 16.42%
R2 14.26 10.97%
R1 13.75 7.00%
Price 12.85
S1 0 -
S2 0 -
S3 0 -

ALPMF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 30, 2027 Mar 30, 2027 Mar 30, 2027 $0.200 1.28%
2 Sep 29, 2026 Sep 29, 2026 Sep 29, 2026 $0.199 1.38%
3 Apr 25, 2025 Mar 31, 2026 Mar 31, 2026 $0.271 2.84%
4 Apr 25, 2025 Sep 30, 2025 Sep 30, 2025 $0.271 2.84%
5 Sep 29, 2025 Sep 29, 2025 Sep 29, 2025 $0 0%

FAQ

What is the symbol for Astellas Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Astellas Pharma, Inc. is ALPMF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Astellas Pharma, Inc. Stock?
Astellas Pharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Astellas Pharma, Inc. Stock?
Astellas Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Astellas Pharma, Inc. Stock.

What's the current price of Astellas Pharma, Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an Astellas Pharma, Inc. (ALPMF) share was $12.85.

What is the 52-week high and low for Astellas Pharma, Inc. Stock?
The 52-week high for Astellas Pharma, Inc. Stock is $17.85 and the 52-week low is $9.34.

What is the market capitalization of Astellas Pharma, Inc. Stock?
As of the Jul 10, 2026, the market capitalization of Astellas Pharma, Inc. is 23.021B.

When is the next earnings date for Astellas Pharma, Inc.?
The upcoming earnings date for Astellas Pharma, Inc. is Aug 05, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE